hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.

2016

hMENA 11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

50

References

10

Citations